A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 5, 2013, Pages 343-353

  Patanwala, Insiyyah Y ^a   Bauer, Heidi M ^a,c   Miyamoto, Justin ^a   Park, Ina U ^a,c   Huchko, Megan J ^b   Smith Mccune, Karen K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

cervical cytology; cervical intraepithelial neoplasia; colposcopy; Papanicolaou test

Indexed keywords

CANCER SCREENING; COLPOSCOPY; CYTOLOGY; DATA BASE; HUMAN; HUMAN PAPILLOMAVIRUS TESTING; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; WART VIRUS;

ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84876672888     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.11.013     Document Type: Review

References (21)

1. US National Institutes of Health. National Cancer Institute Surveillance Epidemiology and End Results. SEER stat fact sheets: cervix uteri http://seer.cancer.gov/statfacts/html/cervix.html Accessed June 21, 2011
2. J.D. Gay, L.D. Donaldson, J.R. Goellner False-negative results in cervical cytologic studies Acta Cytol 29 1985 1043 1046
3. N. Munoz, F.X. Bosch, S. de Sanjosé Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527
4. A.B. Moscicki, S. Shiboski, J. Broering The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women J Pediatr 132 1998 277 284
5. V.A. Moyer US Preventative Services Task Force Screening for Cervical cancer: US Preventive Services Task Force Recommendation Statement Ann Intern Med 156 2012 880 891 W312
6. D. Saslow, D. Solomon, H.W. Lawson American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer CA Cancer J Clin 62 2012 147 172
7. American Society for Colposcopy and Cervical Pathology HPV genotyping clinical update, 2009 http://www.asccp.org/ConsensusGuidelines/ HPVGenotypingClinicalUpdate/tabid/5963/Default.aspx Accessed June 21, 2011
8. M. Arbyn, P. Sasieni, C.J. Meijer, C. Clavel, G. Koliopoulos, J. Dillner Chapter 9: clinical applications of HPV testing: a summary of meta-analyses Vaccine 24 Suppl 3 2006 S3/78-89
9. G. Koliopoulos, M. Arbyn, P. Martin-Hirsch, M. Kyrgiou, W. Prendiville, E. Paraskevaidis Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies Gynecol Oncol 104 2007 232 246
10. P. Macaskill, S. Walter, L. Irwig, E. Franco Assessing the gain in diagnostic performance when combining two diagnostic tests Stat Methods 21 2002 2527
11. International Agency for Research on Cancer IARC Handbooks of cancer prevention, vol. 10: cervix cancer screening. Chapter 4: efficacy of screening http://www.iarc.fr/en/publications/pdfs-online/prev/handbook10/handbook10-chap4. pdf Accessed Feb. 2, 2012
12. G.S. Ogilvie, D.J. van Niekerk, M. Krajden A randomized controlled trial of human papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL trial) BMC Cancer 10 2010 111
13. D. Rijkaart, J. Berkhof, L. Rozendaal Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial Lancet Oncol 13 2012 78 88
14. N.W. Bulkmans Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 2007 1764 1772
15. A. Roposch, N.M. Moreau, E. Uleryk, A.S. Doria Developmental dysplasia of the hip: quality of reporting of diagnostic accuracy for US Radiology 241 2006 854 860
16. G. Ronco, P. Giorgi-Rossi, F. Carozzi Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial Lancet Oncol 11 2010 249 257
17. R. Sankaranarayanan, B.M. Nene, S.S. Shastri HPV screening for cervical cancer in rural India N Engl J Med 360 2009 1385 1394
18. H.C. Kitchener, M. Almonte, C. Thomson HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial Lancet Oncol 10 2009 672 682
19. P. Naucler, W. Ryd, S. Törnberg Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 2007 1589 1597
20. M. Leinonen, P. Nieminen, L. Kotaniemi-Talonen Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting J Natl Cancer Inst 101 2009 1612 1623
21. A.B. Moscicki, Y. Ma, C. Wibbelsman Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women Obstet Gynecol 116 2010 1373 1380